On July 5, the Food and Drug Administration (FDA) approved the first fully absorbable stent to treat coronary artery disease (CAD): Absorb GT1 Bioresorbable Vascular Scaffold System (BVS). Read more
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
